코엔원

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should consider the benefits of taking it against the potential dangers for the baby. Physicians don't have the data to give clear advice however they can provide information on the risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a higher risk of fetal malformations or structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during early pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was correct and to eliminate any bias.

However, the researchers' study was not without its flaws. In particular, they were unable to separate the effects of the medication from the underlying disorder. This makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. The researchers also did not examine long-term outcomes for offspring.

The study revealed that infants whose mothers had taken ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU) as compared to mothers who did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean birth or having a child with an low Apgar score (less than 7). These increases did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications in early pregnancies can be offset by greater benefits for mother and baby of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and, if possible, help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Interactions with Medication

Doctors are increasingly faced with the decision of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are made in the absence of solid and reliable evidence regardless, so doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research says on the topic and their own best judgment for each patient.

Particularly, the subject of potential risks for the baby can be tricky. Many studies on this topic are based on observational evidence rather than controlled research and their conclusions are often contradictory. Most studies limit their analysis to live-births, which could underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion A few studies have revealed a positive correlation between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies show a neutral, or even slight negative effect. In every case an in-depth analysis of the benefits and risks should be conducted.

For women suffering from ADHD, the decision to stop medication is difficult, if not impossible. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness, and family conflict for patients with ADHD. A loss of medication may also affect the ability to drive safely and perform work-related tasks, which are crucial aspects of normal life for people with ADHD.

She suggests that women who are unsure about whether or not to discontinue medication due to their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its impact on daily functioning, and on the benefits of keeping the current treatment plan. Educating them can also make the woman feel more comfortable when she is struggling with her decision. Certain medications can be passed through the placenta. If the patient decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the baby.

Risk of Birth Defects

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases, so does concern about the possible effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. With two massive data sets researchers were able to look at more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medications was associated with a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study found no link between the use of early medications and other congenital abnormalities, such as facial clefting or club foot. The results are in line with previous studies showing a small but significant increase in the risk of cardiac malformations in women who started taking ADHD medications before pregnancy. This risk increased during the latter stages different types of adhd medication pregnancy, when a lot of women stopped taking their medication.

Women who took ADHD medication in the first trimester were more likely require a caesarean birth and also have an insufficient Apgar after delivery and have a baby who needed breathing assistance after birth. The authors of the study were unable to eliminate bias due to selection because they restricted the study to women with no other medical conditions that might have contributed to the findings.

The researchers hope their research will serve to inform the clinical decisions of physicians who treat pregnant women. They advise that while discussing the benefits and risks is important, the decision to stop or keep treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that even though stopping adhd medication adults (try iampsychiatry70631.daneblogger.com) the medication is an option, it is not a recommended practice because of the high incidence of depression and other mental health issues in women who are pregnant or recently post-partum. Further, the research suggests that women who choose to stop taking their medications are more likely to experience difficulties getting used to life without them after the birth of their baby.

Nursing

The responsibilities of being a new mom can be overwhelming. Women with ADHD are often faced with a number of difficulties when they must manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new routines. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk in low amounts. The amount of exposure to medications can i get adhd meds without a diagnosis vary depending upon the dosage, frequency of administration and the time of day. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The effect on a newborn's health is not completely understood.

Because of the lack of research, some physicians may recommend stopping stimulant drugs during the pregnancy of a woman. It is a difficult decision for the woman who must weigh the benefits of taking her medication as well as the potential risks to the embryo. As long as more information is available, doctors can inquire about pregnant patients if they have a background of ADHD or if they are planning to take medication during the perinatal phase.

A growing number of studies have shown that the majority of women are able to safely continue taking their adhd and medication medication while they are pregnant and nursing. In response, a growing number of patients are choosing to do this. They have concluded after consulting with their doctor, that the benefits of continuing their current medication far outweigh any possible risks.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and the underlying disorder, learn about available treatments and to reinforce existing strategies for managing. This should include a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if needed modifications to the medication regime.